Timothy M. Shannon, Director at CytomX Therapeutics, Inc. (CTMX), sold 90,648 shares at $11.64 ($1.1M) on 2016-11-18, disclosed to the SEC on 2016-11-21.
Open-market sale of $1.1M CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.50 | 18,971 | $218K | 20.7% |
| 2 | $11.50 | 18,971 | $218K | 20.7% |
| 3 | $11.64 | 12,805 | $149K | 14.2% |
| 4 | $11.64 | 12,805 | $149K | 14.2% |
| 5 | $11.72 | 13,548 | $159K | 15.1% |
| 6 | $11.72 | 13,548 |
| $159K |
| 15.1% |
| Total | $11.61 avg | 90,648 | $1.1M | 100% |
| Filing → |
| ARVN | SELL | 2021-09-27 | $4.3M | — | Filing → |
| ARVN | SELL | 2021-09-27 | $32.9M | — | Filing → |
| RLYB | BUY | 2021-08-04 | $1000K | — | Filing → |